Wang et al. (Wang et al. 2014) analysed a panel of four potential serum/nipple discharge biomarkers: CEA, CA15-3, CA125 and tumour-specific growth factor (TSGF) in the diagnosis and prognosis of BC. Here, CEACAM5 is linked to breast cancer.